you are looking Caustic Dressing Powder training session

and as the Caustic Dressing Powder judicious
 
Photo :Caustic Dressing Powder

the faculties Caustic Dressing Powder Generic Name: copper sulfate and chloroxylenol Dosage Form: FOR ANIMAL USE ONLY Print this page Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here. Caustic Dressing Powder INDICATIONS INDICATIONS : For use as an aid in the management of slow-healing surface wounds on horses and mules. WARNING : Not for use on horses intended for food. CAUTION CAUTION : In case of deep or puncture wounds or serious burns consult veterinarian. If redness, irritation, or swelling persists or increases, discontinue use and consult veterinarian. DIRECTIONS FOR USE DIRECTIONS FOR USE : Apply powder freely to wounds twice daily. Repeat as indicated. For External Use Only D-1701-04 Rev. 10-96 Enter section text here COMPOSITION : Copper Sulfate 5H 2 O .. 51.5 w/w Chloroxylenol .............. 1.0% w/w in a free-flowing starch base. Not Sterilized. Do not store above 30 o C (86 o F) . Keep container tightly closed when not in use. TAKE TIME OBSERVE LABEL DIRECTIONS Lot No. Exp. Date CAUSTIC DRESSING copper sulfate and chloroxylenol powder Product Information Product Type OTC ANIMAL DRUG Item Code (Source) NDC:58005-701 Route of Administration TOPICAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CUPRIC SULFATE (CUPRIC CATION) CUPRIC SULFATE 73 g in 141.8 g CHLOROXYLENOL (CHLOROXYLENOL) CHLOROXYLENOL 1.42 g in 141.8 g Packaging # Item Code Package Description 1 NDC:58005-701-04 141.8 g in 1 JAR Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 08/11/1995 Labeler - Sparhawk Laboratories, Inc. (958829558) Revised: 01/2010 Sparhawk Laboratories, Inc. FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More professional


arising Caustic Dressing Powder that every one


EmoticonEmoticon